(Q35036657)

5 August 2017

1 reference

title

Prognosis of small hepatocellular carcinoma treated by percutaneous ethanol injection and transcatheter arterial chemoembolization (English)

1 reference

5 August 2017

main subject

hepatocellular carcinoma

1 reference

Chao-Sheng Liao

1

1 reference

5 August 2017

Kuo-Ching Yang

2

1 reference

5 August 2017

Ming-Fang Yen

3

1 reference

5 August 2017

Li-Lian Teng

4

1 reference

5 August 2017

Stephen W Duffy

5

1 reference

5 August 2017

Tony Hsiu-Hsi Chen

6

1 reference

5 August 2017

publication date

1 November 2002

1 reference

Journal of Clinical Epidemiology

5 August 2017

published in

1 reference

5 August 2017

volume

55

1 reference

5 August 2017

issue

11

1 reference

5 August 2017

page(s)

1095-1104

1 reference

Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900487-0

7 January 2021

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900487-0

7 January 2021

Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900487-0

7 January 2021

Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900487-0

7 January 2021

Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900487-0

7 January 2021

Prognosis of hepatocellular carcinoma smaller than 5 cm in relation to treatment: study of 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900487-0

7 January 2021

Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900487-0

7 January 2021

Hepatic resection in 120 patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900487-0

7 January 2021

Personal experience with 411 hepatic resections

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900487-0

7 January 2021

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900487-0

7 January 2021

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900487-0

7 January 2021

Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900487-0

7 January 2021

10.1016/S0895-4356(02)00487-0

Identifiers

DOI

1 reference

5 August 2017

1 reference